Bonito Biosciences
Seed-stage biotechnology company developing a platform to discover tissue-selective delivery agents (small molecules, peptides, antibodies) that can be directly conjugated to therapeutic payloads, with a focus on oligonucleotide and macromolecule delivery and use of AI to generate novel delivery molecules.
Industries
biotechnology
medical
product-research
Nr. of Employees
small (1-50)
Products
Platform for discovery of tissue-targeted delivery agents
Platform to discover agents usable as delivery vehicles that can be conjugated to therapeutic payloads for tissue-selective targeting.
Platform for discovery of tissue-targeted delivery agents
Platform to discover agents usable as delivery vehicles that can be conjugated to therapeutic payloads for tissue-selective targeting.
Services
Collaborative research partnerships
Partnerships and collaboration engagements to apply the company's delivery discovery platform to external programs.
Collaborative research partnerships
Partnerships and collaboration engagements to apply the company's delivery discovery platform to external programs.
Expertise Areas
- Tissue-selective drug delivery
- Oligonucleotide therapeutics
- Display technologies and selection sciences
- Conjugation chemistry for targeted delivery
Key Technologies
- AI-driven molecular generation
- Display-based ligand selection
- Conjugation chemistry
- Peptide and antibody targeting ligand discovery